The FDA's Rejection of Female Viagra Wasn't Sexist. It Was Good Science.

The FDA's Rejection of Female Viagra Wasn't Sexist. It Was Good Science.

When the FDA denied Sprout Pharmaceutical's bid last October to begin marketing flibanserin, a drug aimed at treating low sexual desire in women, women's groups responded in anger. In January, representatives from eight different women's groups, …

3
Like
Save

Comments

Write a comment

*